Latest news
{{'Tue, 17 Nov 2026 08:00:00 -0500' | dateFormatUsFilter}}
Novo launches the new Novocare®: Free support program connects people with Wegovy® in addition to home delivery, everyday support, wellness partners and rewards
Read more
{{'Mon, 16 Nov 2026 17:00:00 -0500' | dateFormatUsFilter}}
Novo presents preclinical and human data suggesting a role for amylin and calcitonin receptor activation in preserving bone during weight loss at ObesityWeek®
Read more
{{'Mon, 16 Nov 2026 10:00:00 -0500' | dateFormatUsFilter}}
Wegovy® resulted in a BMI reduction of 10% or more in almost 80% of children with obesity aged 6 to under 12, compared to 0% with placebo in STEP Young trial, published in The New England Journal of Medicine
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.